Although the genes were selected from different sets of classes, discrepancies of some gene profiles, for example in Cluster 5, may be related to incomplete microarray platform compatibility or to differential cellular environment.
A Goldman class II discrepancy is a missed major diagnosis with equivocal impact on survival.
A Class 1 discrepancy was unlikely to result in clinical deterioration.
A Goldman class I discrepancy is a missed major diagnosis in which the principle, underlying causes of death was missed with probable adverse impact on survival.
Of the 86 patients, 22 (26%) had 25 major missed diagnoses, 12 (54%) patients had class I discrepancies, 7 (32%) had class II discrepancies, and 3 (14%) had both class I and class II discrepancies.
Major missed diagnoses (discordant cases) were noted in 22 patients (26%) (group 1): 12 (54%) patients had class I discrepancies, 7 (32%) had class II discrepancies, and 3 (14%) had both class I and class II discrepancies.
Although attractive at first glance, DDD do not represent the best means of either analysing the appropriateness of an antihypertensive treatment, or comparing costs between different drug classes, as a result of the drug class-specific discrepancy between PDD and DDD.
Class I discrepancies were due to opportunistic infections (67%) and cardiac complications (33%), whereas class II discrepancies were due to cardiopulmonary complications (70%) and opportunistic infections (30%).
These demands have particular relevance for "elective " orthodontics, in which variations in the design and timing of appliances prescribed for seemingly analogous skeletal Class II discrepancies and other forms of malocclusion conflict with accepted standards of accountability.
Class 2 discrepancies were those having the potential to cause moderate clinical deterioration.
